The Worldwide eClinical Solutions Industry is Expected to Reach $20.1 Billion by 2028

News provided by

Jan 13, 2023, 07:30 ET

DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "Global eClinical solutions Market Size, Share & Industry Trends Analysis Report By Delivery Mode, By Product, By Clinical Trials Phase (Phase III, Phase II, Phase IV and Phase I), By End User, By Regional Outlook and Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.

The Global eClinical solutions Market size is expected to reach $20.1 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.

With professional data services as well as the elluminate Clinical Data Cloud, eClinical Solutions assists life sciences enterprises all over the world in accelerating clinical development projects.

The elluminate platform and digital data services provide clients with self-service access to all of their data from a single, central location, as well as comprehensive analytics that aid in the faster and more informed decision-making process for businesses.

For the effective administration of data for clinical trials, a variety of eClinical solutions are employed, that includes electronic data capture & clinical data management systems, randomization and trial supply management, clinical trial management systems, and others. It aids in the efficient integration and management of data produced during clinical studies.

It provides a suite of tools to efficiently organize, manage, track, and create insights for clinical research portfolios. It integrates contact management sites and teams, a calendar and monitoring system, and document management.

As a result, it creates approved clinical research outcomes as well as compliant submissions; stores and regulates data entry; authenticates the reliability and integrity of the data, and makes it possible to improve the patient experiences by accelerating drug development.

COVID-19 Impact Analysis

The market for eClinical solutions is expected to benefit from the COVID-19 pandemic. To expand hospital capacity for patients diagnosed with COVID-19, a significant number of clinics and hospitals around the world underwent restructuring. A potential backlog in non-essential procedures developed as a result of the sharp increase in COVID-19 cases. The lockdown caused delays in the production and delivery of critical medical supplies.

Market Growth Factors

Operational Expenditures and Regulatory Needs are rising

Customized or gene-based disease management is becoming more popular in the field of medical research and innovative drug treatments. In comparison to presently available alternative therapies or medications, government reimbursement organizations, commercial insurers, and payers frequently demand novel drugs that have a better therapeutic value and greater efficacy.

Additionally, by controlling the standard pricing of innovative pharmaceuticals, these payers are reducing manufacturing businesses' profit margins. The eClinical solutions market is concentrating on the development and marketing of software solutions that help speed up and efficiently complete clinical studies.

Rising Adoption of Software Solutions in Clinical Trails

Due to the growing amount of data produced throughout clinical development processes, there is an increased need for recording and analyzing clinical data, which has led to a growth in the use of eClinical solutions in clinical trials.

Furthermore, eClinical technologies improve site performance, clinical trial efficiency, and cost optimization by removing redundant data entry. Also, it is noted that the rapid uptake of eClinical solutions, such as RTSM, combined with effective trial drug supply management, is expected to motivate key companies to increase their investment for product innovations.

Market Restraining Factors

High Cost of Implementation

In order to efficiently manage the clinical research data and information throughout the research lifecycle, researchers might use eClinical solutions. Many integrated eClinical solutions (like CTMS and CDMS) offer clinical researchers end-to-end solutions for all phases of clinical trial administration. These software solutions are, quite costly and charged at a premium rate. With additional costs for technical support cloud-based systems, the installation, and maintenance of eClinical solutions.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in eClinical solutions Market

Chapter 4. Global eClinical Solutions Market by Delivery Mode
4.1 Global Web-based (on-demand) Model Market by Region
4.2 Global Licensed enterprise (on-premise) Model Market by Region
4.3 Global Cloud-based (saas) Model Market by Region

Chapter 5. Global eClinical Solutions Market by Product
5.1 Global CDMS/EDC Solutions Market by Region
5.2 Global CTMS Solutions Market by Region
5.3 Global Analytics & Reporting Platforms Market by Region
5.4 Global Safety Solutions Market by Region
5.5 Global Integration Platforms Market by Region
5.6 Global RTMS Solutions Market by Region
5.7 Global eCOA Solutions Market by Region
5.8 Global Others Market by Region

Chapter 6. Global eClinical Solutions Market by Clinical Trials Phase
6.1 Global Phase III Market by Region
6.2 Global Phase II Market by Region
6.3 Global Phase IV Market by Region
6.4 Global Phase I Market by Region

Chapter 7. Global eClinical Solutions Market by End User
7.1 Global Pharmaceutical & Biopharmaceutical Companies Market by Region
7.2 Global Academic Research Institutions Market by Region
7.3 Global Hospitals Market by Region
7.4 Global Contract Research Organizations Market by Region
7.5 Global Medical Device Manufacturers Market by Region
7.6 Global Others Market by Region

Chapter 8. Global eClinical Solutions Market by Region

Chapter 9. Company Profiles
9.1 Oracle Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Anju Software, Inc.
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Acquisition and Mergers:
9.3 eClinical Solutions LLC
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Acquisition and Mergers:
9.4 Castor EDC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.5 Signant Health
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Product Launches and Product Expansions:
9.6 Dassault Systemes SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.7 Parexel International Corporation (Phoenix Parentco, Inc.)
9.7.1 Company Overview
9.8 Clario
9.8.1 Company Overview
9.9 BSI Life Sciences (Business Systems Integration AG)
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Partnerships, Collaborations, and Agreements:
9.10. MedNet Solutions
9.10.1 Company Overview